{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:18:18Z","timestamp":1785208698930,"version":"3.55.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10585-017-9856-8","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T08:56:44Z","timestamp":1500541004000},"page":"295-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-625X","authenticated-orcid":false,"given":"Ond\u0159ej","family":"Kube\u010dek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9602-7501","authenticated-orcid":false,"given":"Jan","family":"Laco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4887-3196","authenticated-orcid":false,"given":"Ji\u0159\u00ed","family":"\u0160pa\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Petera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4126-0410","authenticated-orcid":false,"given":"Jind\u0159ich","family":"Kopeck\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Kube\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-0745","authenticated-orcid":false,"given":"Stanislav","family":"Filip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"9856_CR1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01700650","volume":"50","author":"FE Krukenberg","year":"1896","unstructured":"Krukenberg FE (1896) \u00dcber Das Fibrosarcoma ovarii mucocellulare (carcinomatodes). Arch Gyn\u00e4kol 50:287\u2013321","journal-title":"Arch Gyn\u00e4kol"},{"key":"9856_CR2","first-page":"1","volume":"14","author":"E Kraus","year":"1901","unstructured":"Kraus E (1901) \u00dcber das zustandekommen der krebsmetastasen im ovarium bei prim\u00e4rem kerbs eines anderen bauchorgans. Monatsschr Geburtsh Gynakol 14:1\u201330","journal-title":"Monatsschr Geburtsh Gynakol"},{"key":"9856_CR3","first-page":"351","volume":"15","author":"JD Woodruff","year":"1960","unstructured":"Woodruff JD, Novak ER (1960) The Krukenberg tumor: study of 48 cases from the ovarian tumor registry. Obstet Gynecol 15:351\u2013360","journal-title":"Obstet Gynecol"},{"issue":"3","key":"9856_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/01.pas.0000190787.85024.cb","volume":"30","author":"T Kiyokawa","year":"2006","unstructured":"Kiyokawa T, Young RH, Scully RE (2006) Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 30(3):277\u2013299. doi:\n                        10.1097\/01.pas.0000190787.85024.cb","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"9856_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.pap.0000213038.85704.e4","volume":"13","author":"RH Young","year":"2006","unstructured":"Young RH (2006) From krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the krukenberg tumor. Adv Anat Pathol 13(5):205\u2013227. doi:\n                        10.1097\/01.pap.0000213038.85704.e4","journal-title":"Adv Anat Pathol"},{"issue":"11","key":"9856_CR6","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1043\/1543-2165(2006)130[1725:ailakt]2.0.co;2","volume":"130","author":"OM Al-Agha","year":"2006","unstructured":"Al-Agha OM, Nicastri AD (2006) An in-depth look at Krukenberg tumor: an overview. Arch Pathol Lab Med 130(11):1725\u20131730. doi:\n                        10.1043\/1543-2165(2006)130[1725:ailakt]2.0.co;2","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"9856_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/gyno.1995.1278","volume":"59","author":"K Fujiwara","year":"1995","unstructured":"Fujiwara K, Ohishi Y, Koike H, Sawada S, Moriya T, Kohno I (1995) Clinical implications of metastases to the ovary. Gynecol Oncol 59(1):124\u2013128. doi:\n                        10.1006\/gyno.1995.1278","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9856_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ygyno.2003.12.039","volume":"93","author":"RG Moore","year":"2004","unstructured":"Moore RG, Chung M, Granai CO, Gajewski W, Steinhoff MM (2004) Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 93(1):87\u201391. doi:\n                        10.1016\/j.ygyno.2003.12.039","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9856_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0090-8258(92)90017-D","volume":"44","author":"E Petru","year":"1992","unstructured":"Petru E, Pickel H, Heydarfadai M, Lahousen M, Haas J, Schaider H, Tamussino K (1992) Nongenital cancers metastatic to the ovary. Gynecol Oncol 44(1):83\u201386","journal-title":"Gynecol Oncol"},{"issue":"2","key":"9856_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ygyno.2005.05.028","volume":"98","author":"A Ayhan","year":"2005","unstructured":"Ayhan A, Guvenal T, Salman MC, Ozyuncu O, Sakinci M, Basaran M (2005) The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol 98(2):235\u2013241. doi:\n                        10.1016\/j.ygyno.2005.05.028","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9856_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3346\/jkms.2009.24.1.114","volume":"24","author":"SJ Lee","year":"2009","unstructured":"Lee SJ, Bae JH, Lee AW, Tong SY, Park YG, Park JS (2009) Clinical characteristics of metastatic tumors to the ovaries. J Korean Med Sci 24(1):114\u2013119. doi:\n                        10.3346\/jkms.2009.24.1.114","journal-title":"J Korean Med Sci"},{"issue":"5","key":"9856_CR12","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00404-011-1847-4","volume":"284","author":"A Kondi-Pafiti","year":"2011","unstructured":"Kondi-Pafiti A, Kairi-Vasilatou E, Iavazzo C, Dastamani C, Bakalianou K, Liapis A, Hassiakos D, Fotiou S (2011) Metastatic neoplasms of the ovaries: a clinicopathological study of 97 cases. Arch Gynecol Obstet 284(5):1283\u20131288. doi:\n                        10.1007\/s00404-011-1847-4","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"9856_CR13","first-page":"241","volume":"35","author":"I Alvarado-Cabrero","year":"2013","unstructured":"Alvarado-Cabrero I, Rodriguez-Gomez A, Castelan-Pedraza J, Valencia-Cedillo R (2013) Metastatic ovarian tumors: a clinicopathologic study of 150 cases. Anal Quant Cytopathol Histopathol 35(5):241\u2013248","journal-title":"Anal Quant Cytopathol Histopathol"},{"issue":"1","key":"9856_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00428-015-1771-2","volume":"467","author":"J Bruls","year":"2015","unstructured":"Bruls J, Simons M, Overbeek LI, Bulten J, Massuger LF, Nagtegaal ID (2015) A national population-based study provides insight in the origin of malignancies metastatic to the ovary. Virchows Arch 467(1):79\u201386. doi:\n                        10.1007\/s00428-015-1771-2","journal-title":"Virchows Arch"},{"issue":"7","key":"9856_CR15","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/IGC.0b013e3181b33cce","volume":"19","author":"YR Waal de","year":"2009","unstructured":"de Waal YR, Thomas CM, Oei AL, Sweep FC, Massuger LF (2009) Secondary ovarian malignancies: frequency, origin, and characteristics. Int J Gynecol Cancer 19(7):1160\u20131165. doi:\n                        10.1111\/IGC.0b013e3181b33cce","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"9856_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejogrb.2009.11.011","volume":"149","author":"WY Kim","year":"2010","unstructured":"Kim WY, Kim TJ, Kim SE, Lee JW, Lee JH, Kim BG, Bae DS (2010) The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries. Eur J Obstet Gynecol Reprod Biol 149(1):97\u2013101. doi:\n                        10.1016\/j.ejogrb.2009.11.011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"9856_CR17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0090-8258(03)00075-1","volume":"89","author":"N Yada-Hashimoto","year":"2003","unstructured":"Yada-Hashimoto N, Yamamoto T, Kamiura S, Seino H, Ohira H, Sawai K, Kimura T, Saji F (2003) Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 89(2):314\u2013317","journal-title":"Gynecol Oncol"},{"issue":"2","key":"9856_CR18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004347-198706000-00008","volume":"6","author":"RI Demopoulos","year":"1987","unstructured":"Demopoulos RI, Touger L, Dubin N (1987) Secondary ovarian carcinoma: a clinical and pathological evaluation. Int J Gynecol Pathol 6(2):166\u2013175","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"9856_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ygyno.2006.11.005","volume":"105","author":"I Skirnisdottir","year":"2007","unstructured":"Skirnisdottir I, Garmo H, Holmberg L (2007) Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990\u20132003: occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol 105(1):166\u2013171. doi:\n                        10.1016\/j.ygyno.2006.11.005","journal-title":"Gynecol Oncol"},{"issue":"3","key":"9856_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1006\/gyno.1997.4811","volume":"66","author":"BE Miller","year":"1997","unstructured":"Miller BE, Pittman B, Wan JY, Fleming M (1997) Colon cancer with metastasis to the ovary at time of initial diagnosis. Gynecol Oncol 66(3):368\u2013371. doi:\n                        10.1006\/gyno.1997.4811","journal-title":"Gynecol Oncol"},{"issue":"4","key":"9856_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000068388","volume":"54","author":"F Kikkawa","year":"2002","unstructured":"Kikkawa F, Shibata K, Ino K, Nomura S, Kajiyama H, Suzuki T, Kawai M, Mizutani S (2002) Preoperative findings in non-gynecologic carcinomas metastasizing to the ovaries. Gynecol Obstet Invest 54(4):221\u2013227. doi:\n                        10.1159\/000068388","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"9856_CR22","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/igc.0000000000000673","volume":"26","author":"V Sal","year":"2016","unstructured":"Sal V, Demirkiran F, Topuz S, Kahramanoglu I, Yalcin I, Bese T, Sozen H, Tokgozoglu N, Salihoglu Y, Turan H, Iyibozkurt C, Kolomuc T, Sofiyeva N, Berkman S, Arvas M (2016) Surgical treatment of metastatic ovarian tumors from extragenital primary sites. Int J Gynecol Cancer 26(4):688\u2013696. doi:\n                        10.1097\/igc.0000000000000673","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"9856_CR23","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/cncr.30424","volume":"123","author":"K Ganesh","year":"2017","unstructured":"Ganesh K, Shah RH (2017) Clinical and genetic determinants of ovarian metastases from colorectal cancer. Cancer 123(7):1134\u20131143. doi:\n                        10.1002\/cncr.30424","journal-title":"Cancer"},{"key":"9856_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4236\/arsci.2016.42005","volume":"4","author":"B Shah","year":"2016","unstructured":"Shah B, Tang W, Karn S (2016) An Up-to-Date Understanding of the \u201cKrukenberg Tumor\u201d Mechanism. Adv Reprod Sci 4:31\u201336. doi:\n                        10.4236\/arsci.2016.42005","journal-title":"Adv Reprod Sci"},{"issue":"11","key":"9856_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/s1470-2045(06)70939-1","volume":"7","author":"DS Tan","year":"2006","unstructured":"Tan DS, Agarwal R, Kaye SB (2006) Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol 7(11):925\u2013934. doi:\n                        10.1016\/s1470-2045(06)70939-1","journal-title":"Lancet Oncol"},{"key":"9856_CR26","doi-asserted-by":"publisher","first-page":"612817","DOI":"10.1155\/2011\/612817","volume":"2011","author":"Y Yamanishi","year":"2011","unstructured":"Yamanishi Y, Koshiyama M, Ohnaka M, Ueda M, Ukita S, Hishikawa K, Nagura M, Kim T, Hirose M, Ozasa H, Shirase T (2011) Pathways of metastases from primary organs to the ovaries. Obstet Gynecol Int 2011:612817. doi:\n                        10.1155\/2011\/612817","journal-title":"Obstet Gynecol Int"},{"issue":"12","key":"9856_CR27","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/s00535-003-1227-3","volume":"38","author":"N Kakushima","year":"2003","unstructured":"Kakushima N, Kamoshida T, Hirai S, Hotta S, Hirayama T, Yamada J, Ueda K, Sato M, Okumura M, Shimokama T, Oka Y (2003) Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor. J Gastroenterol 38(12):1176\u20131180. doi:\n                        10.1007\/s00535-003-1227-3","journal-title":"J Gastroenterol"},{"issue":"1","key":"9856_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0039-6109(16)45934-7","volume":"73","author":"HJ Asbun","year":"1993","unstructured":"Asbun HJ, Hughes KS (1993) Management of recurrent and metastatic colorectal carcinoma. Surg Clin North Am 73(1):145\u2013166","journal-title":"Surg Clin North Am"},{"key":"9856_CR29","volume-title":"Genes that mediate metastasis organotropism","author":"SL Kall","year":"2013","unstructured":"Kall SL, Koblinski JE (2013) Metastatic cancer: clinical and biological perspectives. Genes that mediate metastasis organotropism. Landes Bioscience, Austin"},{"issue":"7175","key":"9856_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451(7175):147\u2013152. doi:\n                        10.1038\/nature06487","journal-title":"Nature"},{"issue":"5","key":"9856_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/carcin\/bgs100","volume":"33","author":"Y Lu","year":"2012","unstructured":"Lu Y, Govindan R, Wang L, Liu PY, Goodgame B, Wen W, Sezhiyan A, Pfeifer J, Li YF, Hua X, Wang Y, Yang P, You M (2012) MicroRNA profiling and prediction of recurrence\/relapse-free survival in stage I lung cancer. Carcinogenesis 33(5):1046\u20131054. doi:\n                        10.1093\/carcin\/bgs100","journal-title":"Carcinogenesis"},{"issue":"3","key":"9856_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.semcancer.2012.03.007","volume":"22","author":"G Lorusso","year":"2012","unstructured":"Lorusso G, Ruegg C (2012) New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol 22(3):226\u2013233. doi:\n                        10.1016\/j.semcancer.2012.03.007","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"9856_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10549-011-1619-7","volume":"132","author":"JC Harrell","year":"2012","unstructured":"Harrell JC, Prat A, Parker JS, Fan C, He X, Carey L, Anders C, Ewend M, Perou CM (2012) Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Res Treat 132(2):523\u2013535. doi:\n                        10.1007\/s10549-011-1619-7","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"9856_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/cjp2.45","volume":"2","author":"S Crobach","year":"2016","unstructured":"Crobach S, Ruano D, van Eijk R, Schrumpf M, Fleuren G, van Wezel T, Morreau H (2016) Somatic mutation profiles in primary colorectal cancers and matching ovarian metastases: identification of driver and passenger mutations. J Pathol Clin Res 2(3):166\u2013174. doi:\n                        10.1002\/cjp2.45","journal-title":"J Pathol Clin Res"},{"issue":"25","key":"9856_CR35","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1200\/jco.2008.16.4814","volume":"26","author":"JW Carlson","year":"2008","unstructured":"Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, Muto MG, Kindelberger D, Crum CP (2008) Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 26(25):4160\u20134165. doi:\n                        10.1200\/jco.2008.16.4814","journal-title":"J Clin Oncol"},{"issue":"3","key":"9856_CR36","first-page":"331","volume":"32","author":"E Papakonstantinou","year":"2011","unstructured":"Papakonstantinou E, Liapis A, Kairi-Vassilatou E, Iavazzo C, Kleanthis CK, Kondi-Pafiti A (2011) Virilizing ovarian Krukenberg tumor in a 27-year-old pregnant woman. A case report and literature review. Eur J Gynaecol Oncol 32(3):331\u2013333","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"9856_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00404-013-2776-1","volume":"288","author":"I Bruchim","year":"2013","unstructured":"Bruchim I, Ben-Harim Z, Piura E, Tepper R, Fishman A (2013) Preoperative clinical and radiological features of metastatic ovarian tumors. Arch Gynecol Obstet 288(3):615\u2013619. doi:\n                        10.1007\/s00404-013-2776-1","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"9856_CR38","first-page":"31","volume":"11","author":"WG McCluggage","year":"2006","unstructured":"McCluggage WG (2006) The value of immunohistochemistry as a diagnostic aid in ovarian neoplasia: a review. AJSP 11(1):31\u201337","journal-title":"AJSP"},{"issue":"1","key":"9856_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ygyno.2005.09.046","volume":"101","author":"R Antila","year":"2006","unstructured":"Antila R, Jalkanen J, Heikinheimo O (2006) Comparison of secondary and primary ovarian malignancies reveals differences in their pre- and perioperative characteristics. Gynecol Oncol 101(1):97\u2013101. doi:\n                        10.1016\/j.ygyno.2005.09.046","journal-title":"Gynecol Oncol"},{"issue":"6","key":"9856_CR40","first-page":"229","volume":"1","author":"GR Varadhachary","year":"2007","unstructured":"Varadhachary GR (2007) Carcinoma of unknown primary origin. Gastrointest Cancer Res 1(6):229\u2013235","journal-title":"Gastrointest Cancer Res"},{"issue":"Suppl 5","key":"9856_CR41","doi-asserted-by":"publisher","first-page":"v133","DOI":"10.1093\/annonc\/mdv305","volume":"26","author":"K Fizazi","year":"2015","unstructured":"Fizazi K, Greco FA, Pavlidis N, Daugaard G, Oien K, Pentheroudakis G (2015) Cancers of unknown primary site: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v133\u2013v138. doi:\n                        10.1093\/annonc\/mdv305","journal-title":"Ann Oncol"},{"key":"9856_CR42","unstructured":"National Comprehensive Cancer Network (2016) Occult primary (cancer of unknown primary [CUP]) (version 2.2016). \n                        https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/occult.pdf\n                        \n                    . Accessed 1 August 2016"},{"issue":"1","key":"9856_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1148\/radiology.219.1.r01ap28213","volume":"219","author":"DL Brown","year":"2001","unstructured":"Brown DL, Zou KH, Tempany CM, Frates MC, Silverman SG, McNeil BJ, Kurtz AB (2001) Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group Study. Radiology 219(1):213\u2013218. doi:\n                        10.1148\/radiology.219.1.r01ap28213","journal-title":"Radiology"},{"issue":"7","key":"9856_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/jclinpath-2011-200390","volume":"65","author":"F Willmott","year":"2012","unstructured":"Willmott F, Allouni KA, Rockall A (2012) Radiological manifestations of metastasis to the ovary. J Clin Pathol 65(7):585\u2013590. doi:\n                        10.1136\/jclinpath-2011-200390","journal-title":"J Clin Pathol"},{"issue":"10","key":"9856_CR45","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00432-015-1978-2","volume":"141","author":"HL Park","year":"2015","unstructured":"Park HL, Yoo Ie R, O JH, Han EJ, Kim SH (2015) F-18 FDG PET\/CT findings of metastatic ovarian tumors from gastrointestinal tract origin. J Cancer Res Clin Oncol 141(10):1871\u20131878. doi:\n                        10.1007\/s00432-015-1978-2","journal-title":"J Cancer Res Clin Oncol"},{"issue":"Suppl 1","key":"9856_CR46","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1148\/rg.27si075517","volume":"27","author":"EL Rosen","year":"2007","unstructured":"Rosen EL, Eubank WB, Mankoff DA (2007) FDG PET, PET\/CT, and breast cancer imaging. Radiographics 27(Suppl 1):S215\u2013229. doi:\n                        10.1148\/rg.27si075517","journal-title":"Radiographics"},{"key":"9856_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-1-61779-062-1_17","volume":"727","author":"TC Kwee","year":"2011","unstructured":"Kwee TC, Basu S, Alavi A (2011) PET and PET\/CT for unknown primary tumors. Methods Mol Biol 727:317\u2013333. doi:\n                        10.1007\/978-1-61779-062-1_17","journal-title":"Methods Mol Biol"},{"issue":"9","key":"9856_CR48","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1634\/theoncologist.2011-0449","volume":"17","author":"AK Moller","year":"2012","unstructured":"Moller AK, Loft A, Berthelsen AK, Pedersen KD, Graff J, Christensen CB, Costa JC, Skovgaard LT, Perell K, Petersen BL, Daugaard G (2012) A prospective comparison of 18F-FDG PET\/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site. Oncologist 17(9):1146\u20131154. doi:\n                        10.1634\/theoncologist.2011-0449","journal-title":"Oncologist"},{"issue":"6","key":"9856_CR49","first-page":"22","volume":"10","author":"K Pepin","year":"2014","unstructured":"Pepin K, del Carmen M, Brown A, Dizon DS (2014) CA 125 and epithelial ovarian cancer: role in screening, diagnosis, and surveillance. Am J Hematol Oncol 10(6):22\u201329","journal-title":"Am J Hematol Oncol"},{"issue":"1\u20132","key":"9856_CR50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000217748","volume":"13","author":"CA Yedema","year":"1992","unstructured":"Yedema CA, Kenemans P, Wobbes T, Thomas CM, Bon GG, Mulder C, Voorhorst FJ, Verstraeten AA, van Kamp GJ, Hilgers J (1992) Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas. Tumour biol 13(1\u20132):18\u201326","journal-title":"Tumour biol"},{"issue":"3","key":"9856_CR51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mpo.2950220303","volume":"22","author":"N Pavlidis","year":"1994","unstructured":"Pavlidis N, Kalef-Ezra J, Briassoulis E, Skarlos D, Kosmidis P, Saferiadis K, Bairaktari E, Bafaloukos D, Maravegias A, Theoharis D et al (1994) Evaluation of six tumor markers in patients with carcinoma of unknown primary. Med Pediatr Oncol 22(3):162\u2013167","journal-title":"Med Pediatr Oncol"},{"issue":"9824","key":"9856_CR52","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/s0140-6736(11)61178-1","volume":"379","author":"N Pavlidis","year":"2012","unstructured":"Pavlidis N, Pentheroudakis G (2012) Cancer of unknown primary site. The Lancet 379(9824):1428\u20131435. doi:\n                        10.1016\/s0140-6736(11)61178-1","journal-title":"The Lancet"},{"issue":"1","key":"9856_CR53","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/PAS.0b013e3180690d2d","volume":"32","author":"AV Yemelyanova","year":"2008","unstructured":"Yemelyanova AV, Vang R, Judson K, Wu LS, Ronnett BM (2008) Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Pathol 32(1):128\u2013138. doi:\n                        10.1097\/PAS.0b013e3180690d2d","journal-title":"Am J Surg Pathol"},{"key":"9856_CR54","volume-title":"WHO classification of tumours of female reproductive organs. World Health Organization classification of tumours","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, International Agency for Research on Cancer, World Health Organization. (2014) WHO classification of tumours of female reproductive organs. World Health Organization classification of tumours, 4th\u00a0edn. International Agency for Research on Cancer, Lyon","edition":"4"},{"issue":"5","key":"9856_CR55","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/1097-0142(19840301)53:5<1164::AID-CNCR2820530523>3.0.CO;2-4","volume":"53","author":"TM Ulbright","year":"1984","unstructured":"Ulbright TM, Roth LM, Stehman FB (1984) Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer 53(5):1164\u20131174","journal-title":"Cancer"},{"issue":"2","key":"9856_CR56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004347-200404000-00004","volume":"23","author":"G Acs","year":"2004","unstructured":"Acs G, Pasha T, Zhang PJ (2004) WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol 23(2):110\u2013118","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"9856_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1043\/1543-2165(2008)132[402:aoitgp]2.0.co;2","volume":"132","author":"K Mittal","year":"2008","unstructured":"Mittal K, Soslow R, McCluggage WG (2008) Application of immunohistochemistry to gynecologic pathology. Arch Pathol Lab Med 132(3):402\u2013423. doi:\n                        10.1043\/1543-2165(2008)132[402:aoitgp]2.0.co;2","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"9856_CR58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jcp.52.4.283","volume":"52","author":"JH Lagendijk","year":"1999","unstructured":"Lagendijk JH, Mullink H, van Diest PJ, Meijer GA, Meijer CJ (1999) Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol 52(4):283\u2013290","journal-title":"J Clin Pathol"},{"issue":"Suppl 2","key":"9856_CR59","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1038\/modpathol.3800312","volume":"18","author":"J Prat","year":"2005","unstructured":"Prat J (2005) Ovarian carcinomas, including secondary tumors: diagnostically challenging areas. Modern Pathol 18(Suppl 2):S99\u2013S111. doi:\n                        10.1038\/modpathol.3800312","journal-title":"Modern Pathol"},{"issue":"1","key":"9856_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1309\/ajcp5uafmsa9zqbz","volume":"138","author":"H Liu","year":"2012","unstructured":"Liu H, Shi J, Wilkerson ML, Lin F (2012) Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 138(1):57\u201364. doi:\n                        10.1309\/ajcp5uafmsa9zqbz","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"9856_CR61","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.pas.0000176429.88702.36","volume":"29","author":"C Tornos","year":"2005","unstructured":"Tornos C, Soslow R, Chen S, Akram M, Hummer AJ, Abu-Rustum N, Norton L, Tan LK (2005) Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol 29(11):1482\u20131489","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"9856_CR62","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1043\/2010-0478-rar.1","volume":"135","author":"LD Truong","year":"2011","unstructured":"Truong LD, Shen SS (2011) Immunohistochemical diagnosis of renal neoplasms. Arch Pathol Lab Med 135(1):92\u2013109. doi:\n                        10.1043\/2010-0478-rar.1","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"9856_CR63","first-page":"426","volume":"9","author":"K Berezowski","year":"1996","unstructured":"Berezowski K, Stastny JF, Kornstein MJ (1996) Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Modern Pathol 9(4):426\u2013429","journal-title":"Modern Pathol"},{"issue":"3","key":"9856_CR64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004347-198203000-00001","volume":"1","author":"C Charpin","year":"1982","unstructured":"Charpin C, Bhan AK, Zurawski VR Jr, Scully RE (1982) Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies. Int J Gynecol Pathol 1(3):231\u2013245","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"9856_CR65","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1053\/hupa.2000.6799","volume":"31","author":"CT Albarracin","year":"2000","unstructured":"Albarracin CT, Jafri J, Montag AG, Hart J, Kuan SF (2000) Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Hum Pathol 31(6):672\u2013677","journal-title":"Hum Pathol"},{"issue":"2","key":"9856_CR66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2559.2003.01687.x","volume":"43","author":"YY Chou","year":"2003","unstructured":"Chou YY, Jeng YM, Kao HL, Chen T, Mao TL, Lin MC (2003) Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin. Histopathology 43(2):151\u2013156","journal-title":"Histopathology"},{"issue":"1","key":"9856_CR67","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.pgp.0000101141.31270.a0","volume":"23","author":"GM Groisman","year":"2004","unstructured":"Groisman GM, Meir A, Sabo E (2004) The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries. Int J Gynecol Pathol 23(1):52\u201357. doi:\n                        10.1097\/01.pgp.0000101141.31270.a0","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"9856_CR68","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/modpathol.2010.204","volume":"24","author":"T Okamoto","year":"2011","unstructured":"Okamoto T, Matsumura N, Mandai M, Oura T, Yamanishi Y, Horiuchi A, Hamanishi J, Baba T, Koshiyama M, Shiozawa T, Konishi I (2011) Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1. Modern Pathol 24(2):267\u2013276. doi:\n                        10.1038\/modpathol.2010.204","journal-title":"Modern Pathol"},{"issue":"2","key":"9856_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1897-4287-6-2-88","volume":"6","author":"J Gronwald","year":"2008","unstructured":"Gronwald J, Byrski T, Huzarski T, Oszurek O, Janicka A, Szyma\u0144ska-Pasternak J, G\u00f3rski B, Menkiszak J, Rzepka-G\u00f3rska I, Lubi\u0144ski J (2008) Hereditary breast and ovarian cancer. Hered Cancer Clin Pract 6 (2):1\u201311. doi:\n                        10.1186\/1897-4287-6-2-88","journal-title":"Hered Cancer Clin Pract"},{"issue":"1","key":"9856_CR70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1309\/tdp92pqlde2hleet","volume":"127","author":"R Bhargava","year":"2007","unstructured":"Bhargava R, Beriwal S, Dabbs DJ (2007) Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol 127(1):103\u2013113. doi:\n                        10.1309\/tdp92pqlde2hleet","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"9856_CR71","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","volume":"32","author":"D Nonaka","year":"2008","unstructured":"Nonaka D, Chiriboga L, Soslow RA (2008) Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 32(10):1566\u20131571. doi:\n                        10.1097\/PAS.0b013e31816d71ad","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"9856_CR72","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00428-014-1574-x","volume":"464","author":"RS Post van der","year":"2014","unstructured":"van der Post RS, Bult P, Vogelaar IP, Ligtenberg MJ, Hoogerbrugge N, van Krieken JH (2014) HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma. Virchows Arch 464(6):673\u2013679. doi:\n                        10.1007\/s00428-014-1574-x","journal-title":"Virchows Arch"},{"issue":"3","key":"9856_CR73","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/01.pgp.0000071044.12278.43","volume":"22","author":"RI Cameron","year":"2003","unstructured":"Cameron RI, Ashe P, O\u2019Rourke DM, Foster H, McCluggage WG (2003) A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma. Int J Gynecol Pathol 22(3):272\u2013276. doi:\n                        10.1097\/01.pgp.0000071044.12278.43","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"9856_CR74","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/1097-0142(19930715)72:2<511::AID-CNCR2820720230>3.0.CO;2-Q","volume":"72","author":"S Masood","year":"1993","unstructured":"Masood S, Rhatigan RM, Wilkinson EW, Barwick KW, Wilson WJ (1993) Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study. Cancer 72(2):511\u2013518. doi:\n                        10.1002\/1097-0142(19930715)72:2<511::AID-CNCR2820720230>3.0.CO;2-Q","journal-title":"Cancer"},{"issue":"1","key":"9856_CR75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2559.1994.tb01270.x","volume":"24","author":"FA Ghandour","year":"1994","unstructured":"Ghandour FA, Attanoos R, Nahar K, Gee JW, Bigrigg A, Ismail SM (1994) Immunocytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the cervix. Histopathology 24(1):49\u201355","journal-title":"Histopathology"},{"issue":"2","key":"9856_CR76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00000478-200302000-00006","volume":"27","author":"G Negri","year":"2003","unstructured":"Negri G, Egarter-Vigl E, Kasal A, Romano F, Haitel A, Mian C (2003) p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 27(2):187\u2013193","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"9856_CR77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.humpath.2003.09.019","volume":"35","author":"J Zubovits","year":"2004","unstructured":"Zubovits J, Buzney E, Yu L, Duncan LM (2004) HMB-45, S-100, NK1\/C3, and MART-1 in metastatic melanoma. Hum Pathol 35(2):217\u2013223","journal-title":"Hum Pathol"},{"issue":"2","key":"9856_CR78","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40291-015-0133-8","volume":"19","author":"FA Greco","year":"2015","unstructured":"Greco FA, Lennington WJ, Spigel DR, Hainsworth JD (2015) Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay. Mol Diagn Ther 19(2):91\u201397. doi:\n                        10.1007\/s40291-015-0133-8","journal-title":"Mol Diagn Ther"},{"issue":"14","key":"9856_CR79","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1158\/1078-0432.ccr-12-0920","volume":"18","author":"SE Kerr","year":"2012","unstructured":"Kerr SE, Schnabel CA, Sullivan PS, Zhang Y, Singh V, Carey B, Erlander MG, Highsmith WE, Dry SM, Brachtel EF (2012) Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier. Clin Cancer Res 18(14):3952\u20133960. doi:\n                        10.1158\/1078-0432.ccr-12-0920","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9856_CR80","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1634\/theoncologist.2011-0466","volume":"17","author":"E Meiri","year":"2012","unstructured":"Meiri E, Mueller WC, Rosenwald S, Zepeniuk M, Klinke E, Edmonston TB, Werner M, Lass U, Barshack I, Feinmesser M, Huszar M, Fogt F, Ashkenazi K, Sanden M, Goren E, Dromi N, Zion O, Burnstein I, Chajut A, Spector Y, Aharonov R (2012) A second-generation microRNA-based assay for diagnosing tumor tissue origin. Oncologist 17(6):801\u2013812. doi:\n                        10.1634\/theoncologist.2011-0466","journal-title":"Oncologist"},{"issue":"2","key":"9856_CR81","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1200\/jco.2012.43.3755","volume":"31","author":"JD Hainsworth","year":"2013","unstructured":"Hainsworth JD, Rubin MS, Spigel DR, Boccia RV, Raby S, Quinn R, Greco FA (2013) Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute. J Clin Oncol 31(2):217\u2013223. doi:\n                        10.1200\/jco.2012.43.3755","journal-title":"J Clin Oncol"},{"issue":"15_suppl","key":"9856_CR82","doi-asserted-by":"publisher","first-page":"TPS11134TPS1113","DOI":"10.1200\/jco.2014.32.15_suppl.tps11134","volume":"32","author":"M Geraldine","year":"2014","unstructured":"Geraldine M, Agnes L, Agnes WVdW, Gedske D, Carmen B, Nicolas P, Loic C, Djelila A, Bruno C, Stephane C, Marine G-G, Yacine M, Cristian M, Elodie V, Isabelle B, Fanny W, Catherine AS, Karim F (2014) GEFCAPI 04: A phase III trial comparing a treatment oriented by a molecular analysis with CancerTYPE ID test to cisplatin-gemcitabine in patients with carcinoma of an unknown primary (CUP). J Clin Oncol 32(15_suppl):TPS11134\u2013TPS11134. doi:\n                        10.1200\/jco.2014.32.15_suppl.tps11134","journal-title":"J Clin Oncol"},{"key":"9856_CR83","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/1471-2407-10-222","volume":"10","author":"JP Meyniel","year":"2010","unstructured":"Meyniel JP, Cottu PH, Decraene C, Stern MH, Couturier J, Lebigot I, Nicolas A, Weber N, Fourchotte V, Alran S, Rapinat A, Gentien D, Roman-Roman S, Mignot L, Sastre-Garau X (2010) A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer. BMC Cancer 10:222. doi:\n                        10.1186\/1471-2407-10-222","journal-title":"BMC Cancer"},{"issue":"4","key":"9856_CR84","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1365-2559.2008.03107.x","volume":"53","author":"P Mhawech-Fauceglia","year":"2008","unstructured":"Mhawech-Fauceglia P, Rai H, Nowak N, Cheney RT, Rodabaugh K, Lele S, Odunsi K (2008) The use of array-based comparative genomic hybridization (a-CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus. Histopathology 53(4):490\u2013495. doi:\n                        10.1111\/j.1365-2559.2008.03107.x","journal-title":"Histopathology"},{"issue":"1","key":"9856_CR85","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejso.2008.05.006","volume":"35","author":"R Jiang","year":"2009","unstructured":"Jiang R, Tang J, Cheng X, Zang RY (2009) Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors. Eur J Surg Oncol 35(1):92\u201397. doi:\n                        10.1016\/j.ejso.2008.05.006","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"9856_CR86","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1096-9098(200011)75:3<186::AID-JSO6>3.0.CO;2-S","volume":"75","author":"D Rayson","year":"2000","unstructured":"Rayson D, Bouttell E, Whiston F, Stitt L (2000) Outcome after ovarian\/adnexal metastectomy in metastatic colorectal carcinoma. J Surg Oncol 75(3):186\u2013192","journal-title":"J Surg Oncol"},{"issue":"3","key":"9856_CR87","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ygyno.2007.02.025","volume":"105","author":"CC McCormick","year":"2007","unstructured":"McCormick CC, Giuntoli RL 2nd, Gardner GJ, Schulick RD, Judson K, Ronnett BM, Vang R, Bristow RE (2007) The role of cytoreductive surgery for colon cancer metastatic to the ovary. Gynecol Oncol 105(3):791\u2013795. doi:\n                        10.1016\/j.ygyno.2007.02.025","journal-title":"Gynecol Oncol"},{"issue":"2","key":"9856_CR88","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ygyno.2004.05.007","volume":"94","author":"JH Cheong","year":"2004","unstructured":"Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH (2004) Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol 94(2):477\u2013482. doi:\n                        10.1016\/j.ygyno.2004.05.007","journal-title":"Gynecol Oncol"},{"issue":"8","key":"9856_CR89","first-page":"3397","volume":"32","author":"LC Lu","year":"2012","unstructured":"Lu LC, Shao YY, Hsu CH, Hsu C, Cheng WF, Lin YL, Cheng AL, Yeh KH (2012) Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer. Anticancer Res 32(8):3397\u20133401","journal-title":"Anticancer Res"},{"issue":"4","key":"9856_CR90","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00268-015-3326-8","volume":"40","author":"F Rosa","year":"2016","unstructured":"Rosa F, Marrelli D, Morgagni P, Cipollari C, Vittimberga G, Framarini M, Cozzaglio L, Pedrazzani C, Berardi S, Baiocchi GL, Roviello F, Portolani N, de Manzoni G, Costamagna G, Doglietto GB, Pacelli F (2016) Krukenberg tumors of gastric origin: the rationale of surgical resection and perioperative treatments in a multicenter western experience. World J Surg 40(4):921\u2013928. doi:\n                        10.1007\/s00268-015-3326-8","journal-title":"World J Surg"},{"issue":"9\u201310","key":"9856_CR91","first-page":"427","volume":"133","author":"L Savey","year":"1996","unstructured":"Savey L, Lasser P, Castaigne D, Michel G, Bognel C, Colau JC (1996) Krukenberg tumors. Analysis of a series of 28 cases. J Chir 133(9\u201310):427\u2013431","journal-title":"J Chir"},{"issue":"3","key":"9856_CR92","first-page":"202","volume":"20","author":"K Mrad","year":"2000","unstructured":"Mrad K, Morice P, Fabre A, Pautier P, Lhomme C, Duvillard P, Sabourin JC (2000) Krukenberg tumor: a clinico-pathological study of 15 cases. Ann Pathol 20(3):202\u2013206","journal-title":"Ann Pathol"},{"issue":"1","key":"9856_CR93","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/gyno.1997.4720","volume":"66","author":"NR Abu-Rustum","year":"1997","unstructured":"Abu-Rustum NR, Aghajanian CA, Venkatraman ES, Feroz F, Barakat RR (1997) Metastatic breast carcinoma to the abdomen and pelvis. Gynecol Oncol 66(1):41\u201344. doi:\n                        10.1006\/gyno.1997.4720","journal-title":"Gynecol Oncol"},{"issue":"6","key":"9856_CR94","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocana A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Nat Cancer Inst 106(6):dju124. doi:\n                        10.1093\/jnci\/dju124","journal-title":"J Nat Cancer Inst"},{"issue":"2","key":"9856_CR95","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/jso.20803","volume":"96","author":"F Erroi","year":"2007","unstructured":"Erroi F, Scarpa M, Angriman I, Cecchetto A, Pasetto L, Mollica E, Bettiol M, Ruffolo C, Polese L, Cillo U, D\u2019Amico DF (2007) Ovarian metastasis from colorectal cancer: prognostic value of radical oophorectomy. J Surg Oncol 96(2):113\u2013117. doi:\n                        10.1002\/jso.20803","journal-title":"J Surg Oncol"},{"issue":"2","key":"9856_CR96","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3748\/wjg.v22.i2.519","volume":"22","author":"G Brandi","year":"2016","unstructured":"Brandi G, De Lorenzo S, Nannini M, Curti S, Ottone M, Dall\u2019Olio FG, Barbera MA, Pantaleo MA, Biasco G (2016) Adjuvant chemotherapy for resected colorectal cancer metastases: literature review and meta-analysis. World J Gastroenterol 22(2):519\u2013533. doi:\n                        10.3748\/wjg.v22.i2.519","journal-title":"World J Gastroenterol"},{"key":"9856_CR97","first-page":"149a","volume":"21","author":"B Langer","year":"2002","unstructured":"Langer B, Bleiberg H, Labianca R, Shepherd L, Nitti D, Marsoni S, Tu D, Sargeant AM, A. F (2002) Fluorouracil (FU) plus leucovorin (I-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC\/NCIC\/CTG\/GIVIO) randomized trial. Proc Am Clin Oncol 21:149a","journal-title":"Proc Am Clin Oncol"},{"issue":"31","key":"9856_CR98","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1200\/jco.2006.06.8353","volume":"24","author":"G Portier","year":"2006","unstructured":"Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordlinger B, Bugat R, Lazorthes F, Bedenne L (2006) Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24(31):4976\u20134982. doi:\n                        10.1200\/jco.2006.06.8353","journal-title":"J Clin Oncol"},{"issue":"8","key":"9856_CR99","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/jso.21403","volume":"100","author":"SY Kim","year":"2009","unstructured":"Kim SY, Kim HJ, Hong YS, Jung KH, Park JW, Choi HS, Oh JH, Park SJ, Kim SH, Nam BH, Chang HJ, Kim DY (2009) Resected colorectal liver metastases: does the survival differ according to postoperative chemotherapy regimen? J Surg Oncol 100(8):713\u2013718. doi:\n                        10.1002\/jso.21403","journal-title":"J Surg Oncol"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-017-9856-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-017-9856-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-017-9856-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T23:22:25Z","timestamp":1502925745000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-017-9856-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["9856"],"URL":"https:\/\/doi.org\/10.1007\/s10585-017-9856-8","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}